Trademarks
NALMEFENE HCL
- Serial number
- 97306650
- Registration number
- Not registered
- Filed
- 2022-03-10
- Registered
- Not registered
- Status
- Abandoned 2026-04-20 (USPTO status code 606, 2026-04-20; as of the dataset)
- Classes
- 005
- Elsewhere
- USPTO TSDR record (current status) ↗
- Source
- TRTDXFAP, file of 2026-04-22
Goods and services
Pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Pharmaceuticals, namely, opioid antagonists; Syringes filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Syringes filled with opioid antagonists; Injectors filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectors filled with opioid antagonists; Injectable pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectable pharmaceuticals, namely, opioid antagonists
Owners
| Owner | Role | Entity | Place | Also on furp.org | Source |
|---|---|---|---|---|---|
| Purdue Pharma L.P. | Original applicant, Owner at publication | Entity Code 13 | Stamford, CT | PURDUE PHARMA L.P. State business registration EXACT high confidence: identical full name and state | TRTDXFAP, file of 2026-04-22 |
Assignment history
No recorded assignments on file for this mark.
USPTO bulk data: the Trademark Case Files Dataset (TRCFECO2; the latest release, March 2024, runs through 2023) for marks, owners, classes and goods and services; the Trademark Assignment Dataset (TRASECO) for assignments. Marks filed in the last 20 years, plus older marks still registered. Status here is read from the dataset’s dates and status code; TSDR has the current status. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.